{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T15:40:13Z","timestamp":1700494813807},"reference-count":18,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T00:00:00Z","timestamp":1299542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cathet Cardio Intervent"],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:styled-content>Objectives<\/jats:styled-content>: To evaluate the efficacy of the new Cobalt\u2013Chromium (Co\u2010Cr) Presillion\u2122 stent for the treatment of high\u2010risk acute myocardial infarction (MI) patients. <jats:styled-content>Background<\/jats:styled-content>: Percutaneous coronary intervention (PCI) with stent represents the gold standard treatment for acute MI. <jats:styled-content>Methods and Results<\/jats:styled-content>: We enrolled patients with high\u2010risk acute MI (either ST\u2010segment elevation MI or non\u2010ST\u2010segment elevation MI) treated with PCI using a new Co\u2010Cr bare metal stent with closed cells design and limited balloon compliance. We considered high\u2010risk features as one of the following: age \u226570 years, ejection fraction \u226435%, glomerular filtration rate \u226460 mL\/min, diabetes mellitus, rescue PCI, or chronic atrial fibrillation or other conditions requiring long\u2010term oral anticoagulation therapy. Primary outcome of the study was rate of major adverse cardiac events (MACE) defined as all\u2010cause death, new MI, and target\u2010vessel revascularization. A total of 129 consecutive patients were enrolled (69 \u00b1 11 years, 74% men): 71 (55%) patients with ST\u2010segment elevation MI and 58 (45%) patients with non\u2010ST\u2010segment elevation MI. A total of 153 vessels (169 lesions and 179 stents) were treated. The device success rate was high (98.8%). In\u2010hospital MACE rate was 5.4% mainly because of death associated with the acute MI. At 1\u2010year follow\u2010up, the MACE rate was 17.3%, with 11% all\u2010cause death (7.9% of cardiac origin), 0.6% of stent thrombosis, and 4.6% target\u2010vessel revascularization. <jats:styled-content>Conclusions<\/jats:styled-content>: The use of the Co\u2010Cr Presillion stent in patients with high\u2010risk acute MI treated invasively seems to be safe and efficacious with optimal deliverability and good long\u2010term outcomes and represents a good option in the treatment of these patients. \u00a9 2011 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ccd.22765","type":"journal-article","created":{"date-parts":[[2010,9,8]],"date-time":"2010-09-08T06:12:00Z","timestamp":1283926320000},"page":"608-614","source":"Crossref","is-referenced-by-count":3,"title":["The PREHAMI (PREsillion\u2122 in high\u2010risk acute myocardial infarction) registry"],"prefix":"10.1002","volume":"77","author":[{"given":"Alessandro","family":"Sciahbasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Pendenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Romagnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Summaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Patrizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerio","family":"Lucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Benedetta","family":"Giannico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Penco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Lioy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,3,8]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/heart.83.3.361"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.12.019"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12113-7"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.23.2908"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00669-6"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2008.11.012"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm355"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.82.4.1193"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067731"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-6-199903160-00002"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.21882"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-009-0061-x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm031"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.02.083"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062006"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.09.046"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61751-7"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV5I4A78"}],"container-title":["Catheterization and Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fccd.22765","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.22765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T14:59:34Z","timestamp":1700492374000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.22765"}},"subtitle":["In\u2010hospital and long\u2010term outcomes"],"short-title":[],"issued":{"date-parts":[[2011,3,8]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["10.1002\/ccd.22765"],"URL":"https:\/\/doi.org\/10.1002\/ccd.22765","archive":["Portico"],"relation":{},"ISSN":["1522-1946","1522-726X"],"issn-type":[{"value":"1522-1946","type":"print"},{"value":"1522-726X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,8]]}}}